Sourav Mukherjee 👨🏻‍🔬

The Industry Day on Novel Alternative Models (NAMs) in Drug Discovery held successfully on 12th June 2026 at IIT Bombay brought together researchers, industry leaders, and innovators to discuss the future of drug discovery. The day featured short presentations by IIT Bombay faculty working across a broad spectrum of technologies, from single-cell data analysis and AI-enabled approaches to droplet microfluidics, organoids, and organ-on-chip systems. The discussions continued through extensive interactions, poster sessions, and laboratory visits. The highlight of the event was two panel discussions involving leaders from industry, CROs, startups, academia, and regulators, including Dr. Taruna Madan Gupta (ICMR), Dr. Abhay Deshpande (Jay Research Foundation), Dr. K. V. S. Narayana Raju (Dr. Reddy’s Laboratories), Dr. Venkat Ramana (Dr. Reddy’s Laboratories), Dr. Kasinath Viswanathan (Zydus), Dr. Amjad Hussain (Canfinis), Dr. Alakesh Das (HiMedia Labs), and Prof. Ashutosh Kumar (IIT Bombay). The presence of representatives from organizations such as Zydus, Biocon, Dr. Reddy’s Laboratories, Yashraj Biotechnology, Unilever, ITC, Jay Research Foundation (JRF), Pfizer, Premas Life Sciences, HiMedia, Avay Biosciences, Deloitte, Karkinos Healthcare, the UK Science & Technology Network, and several other organizations including hospitals fostered productive conversations on future collaborations and innovation. A key outcome of the event was the strong consensus on the need for National validation centre(s) for NAMs; Centres of Excellence to build capabilities and train the workforce; and a consortium model connecting academia, industry, CROs, startups, and regulators. @abhijit_MLab

After 25 years of brave & brilliant work by hundreds of scientists in my lab to understand then safely reverse aging for the first time, it was moving to witness the first human dose being delivered 🥹 nature.com/articles/d4158…

MLab proud moment. Our 2b start-up Organomic was selected as top 136 deep-tech start-ups from 3000+ applicants at #BharatInnovates national demo. Credit to Devashree, Saumya, Aditi, Sourav & team.

@iruletheworldmo Would be crazy if we can use this as caption template for videos.

i never want to read any other way again.

No Nobel for me this year 😅—Medicine, Life Science, Chemistry, Literature or Peace all missed! But thrilled that 3 from our lab joined SAAE meet @ccmb_csir & all 3 bagged awards! Congrats @JDevashree10 @vichare_aditi @jsaumya5 🎉👏🏼💐 Super proud mentor moment.

@Swiggy This is the last time I am ordering. Ordered 350gm size, got 250gm. Not once, but twice in a row. Got refund on 1st but nothing today. Garbage support from Swiggy. POS! NB: I have Swiggy One. Outlet: Nothing but Chicken, Powai. Eager to see what action u take next.

#ICSAPaperOfTheMonth Breast cancer cells resist chemotherapy by entering a transient senescent state and evading immune detection. Instead of dying, they persist and can later escape senescence to drive relapse. Disrupting this cycle could lead to new treatment strategies.

A new study from researchers at the Indian Institute of Technology Bombay, led by Prof. Abhijit Majumder, uncovers how strain fields produced by embedded inhomogeneities within biomaterials influence cell alignment, reshaping our understanding of cell behaviour in development, disease and tissue engineering. iitb.ac.in/research-highl…

🚀 Exciting News! 🚀 Our latest research, "Inhomogeneous Substrate Strain-Driven Long-Range Cellular Patterning," is out now in Cell Reports Physical Science!

Seeking a lab position with H1B sponsorship-to start immediately. My paper, ‘Rejuvenation of Senescent Cells, In Vitro and In Vivo, by Low Frequency Ultrasound,’ just accepted in Aging Cell. Expertise in aging, senescence, cancer, rejuvenation & mechanobiology. DMs open! #H1B

All of us, who work in the area of MechanoBio learnt the subject by reading Prof. Mike Sheet’s papers. He visited our lab, met students, n eventually offered 1 PostDoc & 2 PhD positions. There is probably no one working in this field who is NR touched by Mike. RIP. U’ll b missed.

Brutal & Funny replies - A Thread🧵 1. 😂

In “Techconnect”, the annual outreach program of IITB, MLab members are enjoying their time in our lab stall explaining microfluidics to the visitors across age groups.

doi.org/10.1007/s10815… Excited to share the publication of our AI based tool to determine Y chromosome microdeletions and predict the outcomes of surgical sperm retrieval for ICSI and outcomes of assisted reproduction full text here rdcu.be/d20B7

Ever wondered how Mumbai would look under snow? Here you are. Thanks to AI :)

Had an amazing time with 36 participants from 15 different Asian Univs in a Hands on Workshop for Organ on Chip models. The participants were really happy at the end. Kudos to the TAs (members frm our lab & Prof Sandip Kar’s lab) who did all the Hardwork.

Nobel Prize is NOT about h-index or citations. It is about the emergence of big new fields. So many posts discuss Nobel awardees. And so many misunderstand the Nobel Prize. 📍 A bit of clarification from my side: 1⃣ Nobel Prize is NOT about how useful your work is. It’s about how useful it WILL BE. Science is not about real-world impact. It is about new knowledge, new understanding. It’s about nucleating new ways of thinking. Applications can come decades after the discovery. 2⃣ Nobel Prize is NOT about just doing risky research. Many of us take on risky projects. But most stay as niche studies that could have been done by others. It’s about doing what others are AFRAID to do. It's about looking like a reckless scientist. It’s about succeeding where others have failed (despite numerous attempts). 3⃣ Nobel Prize is NOT about a small study. It’s about nucleating a BIG research direction. It’s about "OMG, I didn't know it's even possible!" Yes, sometimes it takes decades to recognize a scientist. But in many cases, the prize was given to those who published the "nucleating studies" and pushed hard to grow the new field. 4⃣ Nobel Prize NOT about a lot of citations. Metrics doesn't matter. Forget this "Stanford top-2% ranking". Your peers' opinion is what really matters. Are you recognized by your peers SO MUCH that they want to see you as a Nobel Laureate? Do they see you as someone who created their field and made their research possible? Do they see you as their thought leader? ▫️ My HUGE congratulations to all Laureates. AI has changed science a lot. Those who made it possible deserve this recognition. #science #AcademicChatter

@DeepakNModi @top2p_sci Many congratulations 🥳🪅

Humbled to be in the top 2% of scientists. I express gratitude to my current and former students, mentors, collaborators, and well-wishers. @top2p_sci

Looking for a motivated non-NET Master’s graduate willing to work on a fully funded project by @DBTIndia at @FollowDbtNibmg . Prior experience in molecular biology techniques like qPCR, cell culture, FACS and knowledge of Epigenetics is a bonus. Interested may Repost or DM.